Table 2 Clinical and demographic data of the patient cohort used in initial analysis
N | All | Males | Females | Medulloblastoma | ATRT | Germinoma | Controls | Mean age (years) | STDEV age | Mean age (weeks) | STDEV age | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Initial analysis | ALL | 32 | 6.15 | 4.74 | 331.14 | 227.61 | ||||||
MALES | 22 | 8.41 | 4.98 | 439.46 | 238.84 | |||||||
FEMALES | 10 | 4.12 | 3.42 | 233.65 | 164.39 | |||||||
UNKNOWN GENDER | 0 | NaN | NaN | NaN | NaN | |||||||
MEDULLOBLASTOMA | 15 | 8 | 7 | 7.13 | 4.62 | 378.41 | 221.92 | |||||
ATRT | 4 | 1 | 3 | 2.46 | 3.06 | 153.90 | 146.95 | |||||
GERMINOMA | 0 | 0 | 0 | NaN | NaN | NaN | NaN | |||||
CONTROLS | 13 | 13 | 0 | NaN | NaN | NaN | NaN | |||||
FETAL | 0 | 0 | 0 | 0 | 0 | 0 | 0 | NaN | NaN | NaN | NaN | |
INFANT | 3 | 1 | 2 | 1 | 2 | 0 | 0 | 0.34 | 0.30 | 52.53 | 14.18 | |
CHILD | 13 | 5 | 8 | 11 | 2 | 0 | 0 | 5.80 | 3.44 | 314.59 | 165.35 | |
ADOLESCENT | 3 | 3 | 0 | 3 | 0 | 0 | 0 | 13.45 | 1.85 | 681.48 | 88.71 | |
ADULT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | NaN | NaN | NaN | NaN | |
% | ALL | MALES | FEMALES | MEDULLOBLASTOMA | ATRT | GERMINOMA | CONTROLS | |||||
ALL | 100.00% | |||||||||||
MALES | 68.75% | |||||||||||
FEMALES | 31.25% | |||||||||||
UNKNOWN GENDER | 0.00% | |||||||||||
MEDULLOBLASTOMA | 46.88% | 4.97% | 4.35% | |||||||||
ATRT | 12.50% | 0.62% | 1.86% | |||||||||
GERMINOMA | 0.00% | 0.00% | 0.00% | |||||||||
CONTROLS | 40.63% | 8.07% | 0.00% | |||||||||
FETAL | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |||||
INFANT | 9.38% | 0.62% | 1.24% | 0.62% | 1.24% | 0.00% | 0.00% | |||||
CHILD | 40.63% | 3.11% | 4.97% | 6.83% | 1.24% | 0.00% | 0.00% | |||||
ADOLESCENT | 9.38% | 1.86% | 0.00% | 1.86% | 0.00% | 0.00% | 0.00% | |||||
ADULT | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |